Hypoventilation during sleep: risk factors, diagnostic algorithms and therapeutic approaches

A. Simonds (London, United Kingdom)

Source: International Congress 2019 – PG17 Sleep apnoea and hypoventilation: obstruction and more
Session: PG17 Sleep apnoea and hypoventilation: obstruction and more
Session type: Postgraduate Course
Number: 129
Disease area: -

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Simonds (London, United Kingdom). Hypoventilation during sleep: risk factors, diagnostic algorithms and therapeutic approaches. International Congress 2019 – PG17 Sleep apnoea and hypoventilation: obstruction and more

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Obesity, sleep apnoea and COVID-19: relationship, risk and therapeutic implications
Source: Sleep and Breathing Conference 2021
Year: 2021


Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation
Source: Eur Respir J 2011; 38: 749-751
Year: 2011


Sleep and breathing in neuromuscular diseases: pathophysiology, screening, and treatment options
Source: Sleep and Breathing Conference 2017
Year: 2017

Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches
Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019
Year: 2020



Techniques for predicting outcome of therapeutic interventions in respiratory disorders during sleep
Source: Annual Congress 2007 - PG21 - Diagnostic and therapeutic aspects of respiratory disorders during sleep
Year: 2007



Hypoventilation in obesity: pathophysiology and clinical approach
Source: ERS Conference
Year: 2015

Central sleep apnoea: phenotypes, differentiation and therapeutic approaches
Source: International Congress 2019 – PG17 Sleep apnoea and hypoventilation: obstruction and more
Year: 2019


Genome-based risk prediction of asthma and COPD: applicability and psychological issues
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012


Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
Source: Eur Respir J 2007; 29: 156-178
Year: 2007



Home sleep apnoea testing: Indications, reliability, and new tools
Source: Sleep and Breathing Conference 2021
Year: 2021


Obesity hypoventilation syndrome: new insights in definitions, severity grades and treatment
Source: Sleep and Breathing Conference 2017
Year: 2017

Are psychological therapies useful in the treatment of sleep apnoea syndrome?
Source: Annual Congress 2004 - What's new in the treatment of sleep apnoea
Year: 2004

Disease definitions in respiratory and sleep medicine: changes in diagnostic criteria and categories over time and clinical implications
Source: Breathe, 17 (3) 210117; 10.1183/20734735.0117-2021
Year: 2021



Cardiovascular risk factors: current treatment strategies shaped for the pneumologist
Source: Annual Congress 2012 - COPD and OSA: two prevalent diseases related to cardiovascular disease by common mechanism?
Year: 2012


Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014


Unbiased approaches to asthma stratification: the road to novel therapies
Source: International Congress 2017 – PG15 Asthma stratification
Year: 2017


Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021


Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach
Source: Guideline 2008
Year: 2008